Thomas A. Raffin

Insider Reports History

Entity
Individual
Location
C/O Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Aimes, IA
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas A. Raffin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akoya Biosciences, Inc. Director Common Stock 15.9M $71.3M $4.48 Jun 12, 2023 Indirect
Akoya Biosciences, Inc. Director Common Stock 235K $1.05M $4.48 Jun 12, 2023 Thomas A. Raffin Living Trust dated March 29, 2017
Akoya Biosciences, Inc. Director Stock Option (Right to Buy) 50K Jun 4, 2024 Direct
LUMOS PHARMA, INC. Director Stock Option (Right to Buy) 3.33K Jun 5, 2024 Direct

Insider Reports Filed by Thomas A. Raffin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
(LUMO) LUMOS PHARMA, INC. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
AKYA Akoya Biosciences, Inc. Jun 4, 2024 1 $0 4 Jun 5, 2024 Director
AKYA Akoya Biosciences, Inc. Jun 12, 2023 3 $10.1M 4 Jun 12, 2023 Director
AKYA Akoya Biosciences, Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
LUMO LUMOS PHARMA, INC. May 10, 2023 1 $0 4 May 12, 2023 Director
LUMO LUMOS PHARMA, INC. Aug 25, 2022 1 $9.73K 4 Aug 26, 2022 Director
AKYA Akoya Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
LUMO LUMOS PHARMA, INC. May 5, 2022 1 $0 4 May 9, 2022 Director
AKYA Akoya Biosciences, Inc. May 21, 2021 0 $0 4/A Sep 16, 2021 Director
LUMO LUMOS PHARMA, INC. May 20, 2021 2 $0 4 May 24, 2021 Director